4-year Fellowship - endpoint toxicity for a mixture of chemicals
Estimated value
£670k
Awarded value
—
Suppliers
0
Lots
1
Published
26 Mar 2026
Description
This research project being tendered links to the FSA Strategy 2022-2027. This strategy is based around the FSA’s mission, food you can trust, alongside three key pillars: food is safe; food is what it says it is; food is healthier and more sustainable. The proposed project focuses on the first pillar, that food is safe, and by generating a new scientific case study focused on the assessment of mixtures of chemicals using in-silico and in-vitro New Approach Methodologies (NAMs), it will enable us to further protect consumers from chemical hazards and enable consumers to be empowered to make informed choices around the food that they eat. The Chemical, Radiological and Allergy (Food Hypersensitivity) Research and Evidence Programme (ChemRA REP) is a wider programme of work, under which this research project will sit. This research programme covers one of the FSAs Areas of research interest | Food Standards Agency (ARI) and sits under research priority two: chemical, radiological, and food hypersensitivity risks. Chemicals are present in food and feed whether they are added intentionally, the result of contamination, malicious intent, or simply naturally occurring. The main aim of this Research Programme is to conduct research on these chemicals, which may be present in food and feed. This research aligns with the FSA’s second Area of Research Interest on chemicals, specifically addressing the question: What new analytical tests or novel approach methods can we use to assess these hazards and their impact on consumers?’. The goal of this project is to use in-silico and in-vitro NAMs to assess the hazards from chemical mixtures in food, and their impact on consumers, from assessing human relevant endpoints. The project also aims to develop cross government collaboration by aiming to improve data systems, encourage collaborative working, and enhance scientific capability across government departments.
Scope
- Reference
- C430597
- Total value
- £670,000 excluding VAT£804,000 including VATAbove the relevant threshold
- Commercial tool
- Standalone contract
- Contract dates
- 14 Jun 2026 to 31 Mar 2030Possible extension to 30 Sept 2030
Optional 6-month extension. Breakpoints: Continuation of the contract will be subject to (1) successful recruitment of the Fellow within 4–6 months of contract start, and (2) satisfactory annual progress reviews each March, to align with agreed milestones, the annual Committee on Toxicity presentation, and annual written updates.
- Main category
- services
- CPV classifications
- 7300000073200000
- Particular suitability
- Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Technical | See Specification for more details. The technical criteria is broken down into sections. | quality | 80.00% |
| Commercial | See specification for more details. The Commercial section is split into 5 sub-sections. | cost | 20.00% |
Participation
Conditions suppliers must meet to bid.
See PSQ
See Technical Envelope and Specification
Submission & procedure
- Enquiry deadline
- 13 Apr 2026, 11:00 am
- Submission deadline
- 30 Apr 2026, 11:00 am
- Submission address
- Tenders for FSA funded projects must be submitted through the health-family single e-Commercial System (Atamis), using the following link: https://health-family.force.com/s/Welcome
- Electronic submission
- Yes
- Procedure
- Open procedure